BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Aerie Pharmaceuticals, Inc. Looks to Raise $15 Million


12/20/2012 8:10:18 AM

Duke spinoff Aerie Pharmaceuticals is looking for $15 million in debt financing, according to a security filing. Aerie has been developing a glaucoma treatment and netted positive results last month for a Phase 2a study of its once-daily eye drop treatment. The company, which netted more than $41 million in an equity round last year, has raised $3 million so far in its latest debt round with $12 million left to go. The first sale happened earlier this month. According to the filing, the financing comes with the option to acquire another security. Five investors have participated so far and, according to the filing, $1.3 million of the offering is being proposed to be used for payments of executive officers, directors or promoters.


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES